- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/10 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
Patent holdings for IPC class C07D 211/10
Total number of patents in this class: 51
10-year publication summary
|
4
|
2
|
7
|
2
|
6
|
2
|
3
|
2
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ludwig-Maximilians-Universitat Munchen | 345 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 950 |
3 |
| Immunomet Therapeutics Inc. | 31 |
3 |
| Bristol-myers Squibb Company | 4880 |
2 |
| Neuropore Therapies, Inc. | 38 |
2 |
| Northeastern University | 1193 |
2 |
| Shenzhen Shenxin Biotechnology Co., Ltd. | 25 |
2 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| AstraZeneca AB | 2892 |
1 |
| Merck Patent GmbH | 5815 |
1 |
| California Institute of Technology | 3977 |
1 |
| Board of Regents, The University of Texas System | 5808 |
1 |
| President and Fellows of Harvard College | 5986 |
1 |
| Auspex Pharmaceuticals, Inc. | 181 |
1 |
| Cadila Healthcare Limited | 317 |
1 |
| ChemoCentryx, Inc. | 386 |
1 |
| Emory University | 1622 |
1 |
| Kyushu University, National University Corporation | 1654 |
1 |
| MannKind Corporation | 523 |
1 |
| Mercer University | 7 |
1 |
| Other owners | 20 |